{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:17:05Z","timestamp":1793881025901,"version":"4.7.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07991"],"award-info":[{"award-number":["22K07991"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22fk0210112h"],"award-info":[{"award-number":["22fk0210112h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Viral Hepatitis Research Foundation of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic hepatitis B virus (HBV) infection is a major medical concern worldwide. Current treatments for HBV infection effectively inhibit virus replication; however, these treatments cannot cure HBV and novel treatment-strategies should be necessary. In this study, we identified tripartite motif-containing protein 26 (TRIM26) could be a supportive factor for HBV replication. Small interfering RNA-mediated TRIM26 knockdown (KD) modestly attenuated HBV replication in human hepatocytes. Endogenous TRIM26 physically interacted with HBV core protein (HBc), but not polymerase and HBx, through the TRIM26 SPRY domain. Unexpectedly, TRIM26 inhibited HBc ubiquitination even though TRIM26 is an E3 ligase. HBc was degraded by TRIM26 KD in Huh-7 cells, whereas the reduction was restored by a proteasome inhibitor. RING domain-deleted TRIM26 mutant (TRIM26\u0394R), a dominant negative form of TRIM26, sequestered TRIM26 from HBc, resulting in promoting HBc degradation. Taking together, this study demonstrated that HBV utilizes TRIM26 to avoid the proteasome-dependent HBc degradation. The interaction between TRIM26 and HBc might be a novel therapeutic target against HBV infection.<\/jats:p>","DOI":"10.1038\/s41598-023-40688-3","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T09:03:23Z","timestamp":1692608603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein"],"prefix":"10.1038","volume":"13","author":[{"given":"Yuki","family":"Nakaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Nishitsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Onomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"40688_CR1","unstructured":"WHO TEAM & Global HIV, H. and S. T. I. P. Global hepatitis report, 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241565455 (2017)."},{"key":"40688_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJM198110293051807","volume":"305","author":"DA Shafritz","year":"1981","unstructured":"Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J. & Kew, M. C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma\u2014studies in percutaneous liver biopsies and post-mortem tissue specimens. N. Engl. J. Med. 305, 1067\u20131073 (1981).","journal-title":"N. Engl. J. Med."},{"key":"40688_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0092-8674(82)90097-6","volume":"29","author":"N Ruiz-Opazo","year":"1982","unstructured":"Ruiz-Opazo, N., Chakraborty, P. R. & Shafritz, D. A. Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum dane particles: Possible implications in persistent HBV infection. Cell 29, 129\u2013138 (1982).","journal-title":"Cell"},{"key":"40688_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/mt.2013.170","volume":"21","author":"K Bloom","year":"2013","unstructured":"Bloom, K., Ely, A., Mussolino, C., Cathomen, T. & Arbuthnot, P. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol. Ther. 21, 1889\u20131897 (2013).","journal-title":"Mol. Ther."},{"key":"40688_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.omtn.2020.03.005","volume":"20","author":"YC Yang","year":"2020","unstructured":"Yang, Y. C. et al. Permanent Inactivation of HBV genomes by CRISPR\/Cas9-mediated non-cleavage base editing. Mol. Ther. Nucleic Acids 20, 480\u2013490 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"40688_CR6","doi-asserted-by":"publisher","first-page":"e02888","DOI":"10.1128\/mbio.02888-21","volume":"13","author":"MG Martinez","year":"2022","unstructured":"Martinez, M. G. et al. CRISPR-Cas9 targeting of hepatitis B virus covalently closed circular DNA generates transcriptionally active episomal variants. mBio 13, e02888\u201321 (2022).","journal-title":"MBio"},{"key":"40688_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646\u2013650 (2002).","journal-title":"Nature"},{"key":"40688_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nature02343","volume":"427","author":"M Stremlau","year":"2004","unstructured":"Stremlau, M. et al. The cytoplasmic body component TRIM5\u03b1 restricts HIV-1 infection in Old World monkeys. Nature 427, 848\u2013853 (2004).","journal-title":"Nature"},{"key":"40688_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJD Neil","year":"2008","unstructured":"Neil, S. J. D., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425\u2013430 (2008).","journal-title":"Nature"},{"key":"40688_CR10","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1128\/JVI.02675-15","volume":"90","author":"W Li","year":"2016","unstructured":"Li, W. et al. Encoded by ORF52, Is an abundant tegument protein and Is. J. Virol. 90, 5329\u20135342 (2016).","journal-title":"J. Virol."},{"key":"40688_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.chom.2017.01.001","volume":"21","author":"YZ Fu","year":"2017","unstructured":"Fu, Y. Z. et al. Human cytomegalovirus tegument protein UL82 inhibits STING-mediated signaling to evade antiviral immunity. Cell Host Microbe 21, 231\u2013243 (2017).","journal-title":"Cell Host Microbe"},{"key":"40688_CR12","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","volume":"182","author":"S Tsukuda","year":"2020","unstructured":"Tsukuda, S. & Watashi, K. Hepatitis B virus biology and life cycle. Antiviral Res. 182, 104925 (2020).","journal-title":"Antiviral Res."},{"key":"40688_CR13","doi-asserted-by":"publisher","first-page":"21840","DOI":"10.18632\/oncotarget.4808","volume":"6","author":"K Miyakawa","year":"2015","unstructured":"Miyakawa, K. et al. Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy. Oncotarget 6, 21840\u201321852 (2015).","journal-title":"Oncotarget"},{"key":"40688_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jhep.2010.12.042","volume":"55","author":"T Lang","year":"2011","unstructured":"Lang, T. et al. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway. J. Hepatol. 55, 762\u2013769 (2011).","journal-title":"J. Hepatol."},{"key":"40688_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-virology-092917-043323","volume":"5","author":"M Van Gent","year":"2018","unstructured":"Van Gent, M., Sparrer, K. M. J. & Gack, M. U. TRIM proteins and their roles in antiviral host defenses. Annu. Rev. Virol. 5, 385\u2013405 (2018).","journal-title":"Annu. Rev. Virol."},{"key":"40688_CR16","doi-asserted-by":"publisher","first-page":"e1004726","DOI":"10.1371\/journal.ppat.1004726","volume":"11","author":"P Wang","year":"2015","unstructured":"Wang, P., Zhao, W., Zhao, K., Zhang, L. & Gao, C. TRIM26 negatively regulates interferon-\u03b2 production and antiviral response through polyubiquitination and degradation of nuclear IRF3. PLoS Pathog. 11, e1004726 (2015).","journal-title":"PLoS Pathog."},{"key":"40688_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/v13010070","volume":"13","author":"T Dhawan","year":"2021","unstructured":"Dhawan, T. et al. TRIM26 facilitates HSV-2 infection by downregulating antiviral responses through the IRF3 pathway. Viruses 13, 70 (2021).","journal-title":"Viruses"},{"key":"40688_CR18","doi-asserted-by":"publisher","first-page":"eabd9732","DOI":"10.1126\/sciadv.abd9732","volume":"7","author":"Y Liang","year":"2021","unstructured":"Liang, Y. et al. TRIM26 is a critical host factor for HCV replication and contributes to host tropism. Sci. Adv. 7, eabd9732 (2021).","journal-title":"Sci. Adv."},{"key":"40688_CR19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/cas.12799","volume":"106","author":"H Nishitsuji","year":"2015","unstructured":"Nishitsuji, H. et al. Novel reporter system to monitor early stages of the hepatitis B virus life cycle. Cancer Sci. 106, 1616\u20131624 (2015).","journal-title":"Cancer Sci."},{"key":"40688_CR20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","volume":"16","author":"A Wack","year":"2015","unstructured":"Wack, A., Terczy\u0144ska-Dyla, E. & Hartmann, R. Guarding the frontiers: The biology of type III interferons. Nat. Immunol. 16, 802\u2013809 (2015).","journal-title":"Nat. Immunol."},{"key":"40688_CR21","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.4049\/jimmunol.179.6.3434","volume":"179","author":"PI \u00d6sterlund","year":"2007","unstructured":"\u00d6sterlund, P. I., Pietil\u00e4, T. E., Veckman, V., Kotenko, S. V. & Julkunen, I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-\u03bb) genes. J. Immunol. 179, 3434\u20133442 (2007).","journal-title":"J. Immunol."},{"key":"40688_CR22","doi-asserted-by":"publisher","first-page":"e00196","DOI":"10.1128\/JVI.00196-19","volume":"93","author":"B Mitra","year":"2019","unstructured":"Mitra, B. et al. Hepatitis B virus precore protein p22 inhibits alpha interferon. J. Virol. 93, e00196\u201319 (2019).","journal-title":"J. Virol."},{"key":"40688_CR23","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1128\/JVI.77.13.7166-7173.2003","volume":"77","author":"J-H Kim","year":"2003","unstructured":"Kim, J.-H., Kang, S., Kim, J. & Ahn, B.-Y. Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein. J. Virol. 77, 7166\u20137173 (2003).","journal-title":"J. Virol."},{"key":"40688_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10529-011-0751-0","volume":"34","author":"G Qian","year":"2012","unstructured":"Qian, G. et al. NIRF, a novel ubiquitin ligase, interacts with hepatitis B virus core protein and promotes its degradation. Biotechnol. Lett. 34, 29\u201336 (2012).","journal-title":"Biotechnol. Lett."},{"key":"40688_CR25","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/jmv.20939","volume":"79","author":"S Braun","year":"2007","unstructured":"Braun, S. et al. Proteasomal degradation of core protein variants from chronic hepatitis B patients sabine. J. Med. Virol. 79, 1312\u20131321 (2007).","journal-title":"J. Med. Virol."},{"key":"40688_CR26","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3390\/cells9122547","volume":"9","author":"H Langerov\u00e1","year":"2020","unstructured":"Langerov\u00e1, H. et al. Hepatitis B core protein is post-translationally modified through K29-linked ubiquitination. Cells 9, 2547 (2020).","journal-title":"Cells"},{"key":"40688_CR27","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1038\/s41467-021-26653-6","volume":"12","author":"T Mahlokozera","year":"2021","unstructured":"Mahlokozera, T. et al. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. Nat. Commun. 12, 6321 (2021).","journal-title":"Nat. Commun."},{"key":"40688_CR28","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/MCB.00465-13","volume":"33","author":"MM-U Zaman","year":"2013","unstructured":"Zaman, M.M.-U. et al. Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 33, 4971\u20134984 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"40688_CR29","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.celrep.2018.11.002","volume":"25","author":"I Lassot","year":"2018","unstructured":"Lassot, I. et al. The E3 ubiquitin ligases TRIM17 and TRIM41 modulate \u03b1-synuclein expression by regulating ZSCAN21. Cell Rep. 25, 2484\u20132496 (2018).","journal-title":"Cell Rep."},{"key":"40688_CR30","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1128\/JVI.02644-08","volume":"83","author":"ML Garcia","year":"2009","unstructured":"Garcia, M. L., Byfield, R. & Robek, M. D. Hepatitis B virus replication and release are independent of core lysine ubiquitination. J. Virol. 83, 4923\u20134933 (2009).","journal-title":"J. Virol."},{"key":"40688_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pro.2185","volume":"22","author":"AA D\u2019Cruz","year":"2013","unstructured":"D\u2019Cruz, A. A., Babon, J. J., Norton, R. S., Nicola, N. A. & Nicholson, S. E. Structure and function of the SPRY\/B30.2 domain proteins involved in innate immunity. Protein Sci. 22, 1\u201310 (2013).","journal-title":"Protein Sci."},{"key":"40688_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jmcb\/mjv068","volume":"8","author":"Y Ran","year":"2016","unstructured":"Ran, Y. et al. Autoubiquitination of TRIM26 links TBK1 to NEMO in RLR-mediated innate antiviral immune response. J. Mol. Cell Biol. 8, 31\u201343 (2016).","journal-title":"J. Mol. Cell Biol."},{"key":"40688_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molcel.2020.11.047","volume":"81","author":"K Kato","year":"2021","unstructured":"Kato, K. et al. Structural analysis of RIG-I-like receptors reveals ancient rules of engagement between diverse RNA helicases and TRIM ubiquitin ligases. Mol. Cell 81, 599\u2013613 (2021).","journal-title":"Mol. Cell"},{"key":"40688_CR34","doi-asserted-by":"publisher","first-page":"104816","DOI":"10.1016\/j.antiviral.2020.104816","volume":"179","author":"A Kuipery","year":"2020","unstructured":"Kuipery, A., Gehring, A. J. & Isogawa, M. Mechanisms of HBV immune evasion. Antiviral Res. 179, 104816 (2020).","journal-title":"Antiviral Res."},{"key":"40688_CR35","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/apt.17124","volume":"56","author":"M Luo","year":"2022","unstructured":"Luo, M. et al. TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFN\u03b1 treatment response of HBeAg-positive chronic hepatitis B patients. Aliment. Pharmacol. Ther. 56, 878\u2013889 (2022).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"40688_CR36","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1099\/jgv.0.000566","volume":"97","author":"T Nishizawa","year":"2016","unstructured":"Nishizawa, T. et al. Enhanced pregenomic RNA levels and lowered precore mRNA transcription efficiency in a genotype A hepatitis B virus genome with C1766T and T1768A mutations obtained from a fulminant hepatitis patient. J. Gen. Virol. 97, 2643\u20132656 (2016).","journal-title":"J. Gen. Virol."},{"key":"40688_CR37","doi-asserted-by":"publisher","first-page":"10563","DOI":"10.1128\/JVI.01398-13","volume":"87","author":"Y Nakaya","year":"2013","unstructured":"Nakaya, Y., Koshi, K., Nakagawa, S., Hashizume, K. & Miyazawa, T. Fematrin-1 is involved in fetomaternal cell-to-cell fusion in bovinae placenta and has contributed to diversity of ruminant placentation. J. Virol. 87, 10563\u201310572 (2013).","journal-title":"J. Virol."},{"key":"40688_CR38","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1128\/JVI.00288-14","volume":"88","author":"Y Nakaya","year":"2014","unstructured":"Nakaya, Y. & Miyazawa, T. Dysfunction of bovine endogenous retrovirus K2 envelope glycoprotein is related to unsuccessful intracellular trafficking. J. Virol. 88, 6896\u20136905 (2014).","journal-title":"J. Virol."},{"key":"40688_CR39","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.3390\/ijms231911613","volume":"23","author":"SMR Konis","year":"2022","unstructured":"Konis, S. M. R., Hughes, J. R. & Parsons, J. L. TRIM26 maintains cell survival in response to oxidative stress through regulating DNA glycosylase stability. Int. J. Mol. Sci. 23, 11613 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"40688_CR40","doi-asserted-by":"publisher","first-page":"e00944","DOI":"10.1128\/mBio.00944-17","volume":"8","author":"Y Nakaya","year":"2017","unstructured":"Nakaya, Y., Lilue, J., Stavrou, S., Moran, E. A. & Ross, S. R. AIM2-like receptors positively and negatively regulate the interferon response induced by cytosolic DNA. mBio 8, e00944\u201317 (2017).","journal-title":"MBio"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40688-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:12:22Z","timestamp":1700475142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40688-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13584"}}